Alpha 2(I) collagen deficient oim mice have altered biomechanical integrity, collagen content, and collagen crosslinking of their thoracic aorta.

Collagen and elastin are the primary determinants of vascular integrity, with elastin hypothesized to be the major contributor to aortic compliance and type I collagen the major contributor to aortic strength and stiffness. Type I collagen is normally heterotrimeric composed of two alpha1(I) and one alpha2(I) collagen chains, alpha1(I)(2)alpha2(I). Recent investigations have reported that patients with recessively inherited forms of Ehlers Danlos syndrome that fail to synthesize proalpha2(I) chains have increased risks of cardiovascular complications. To assess the role of alpha2(I) collagen in aortic integrity, we used the osteogenesis imperfecta model (oim) mouse. Oim mice, homozygous for a COL1A2 mutation, synthesize only homotrimeric type I collagen, alpha1(I)3. We evaluated thoracic aortas from 3-month-old oim, heterozygote, and wildtype mice biomechanically for circumferential breaking strength (Fmax) and stiffness (IEM), histologically for morphological differences, and biochemically for collagen content and crosslinking. Circumferential biomechanics of oim and heterozygote descending thoracic aortas demonstrated the anticipated reduced Fmax and IEM relative to wildtype mice. Histological analyses of oim descending aortas demonstrated reduced collagen staining relative to wildtype aortas suggesting decreased collagen content, which hydroxyproline analyses of ascending and descending oim aortas confirmed. These findings suggest the reduced oim thoracic aortic integrity correlates with the absence of the alpha2(I)collagen chains and in part with reduced collagen content. However, oim ascending aortas also demonstrated a significant increase in pyridinoline crosslinks/collagen molecule as compared to wildtype ascending aortas. The role of increased collagen crosslinks is uncertain; increased crosslinking may represent a compensatory mechanism for the decreased integrity.

[1]  T. Liem,et al.  The role of type I collagen in aortic wall strength with a homotrimeric. , 2001, Journal of vascular surgery.

[2]  F. Ramirez,et al.  Elastic and collagenous networks in vascular diseases. , 2000, Cell structure and function.

[3]  D. A. Bradley,et al.  Oim mice exhibit altered femur and incisor mineral composition and decreased bone mineral density. , 2000, Bone.

[4]  P. Fratzl,et al.  Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress. , 1997, The Journal of clinical investigation.

[5]  R. Bank,et al.  Ageing and zonal variation in post-translational modification of collagen in normal human articular cartilage. The age-related increase in non-enzymatic glycation affects biomechanical properties of cartilage. , 1998, The Biochemical journal.

[6]  Y. Fung Mechanical Properties and Active Remodeling of Blood Vessels , 1993 .

[7]  P. Fratzl,et al.  Fibrillar structure and mechanical properties of collagen. , 1998, Journal of structural biology.

[8]  H. Oxlund,et al.  Inhibition of cross-links in collagen is associated with reduced stiffness of the aorta in young rats. , 1998, Atherosclerosis.

[9]  C. Kielty,et al.  The Collagen Family: Structure, Assembly, and Organization in the Extracellular Matrix , 2003 .

[10]  I. Damjanov,et al.  Synthesis of type I homotrimer collagen molecules by cultured human lung adenocarcinoma cells. , 1988, The American journal of pathology.

[11]  T. Sasaki,et al.  Ehlers-Danlos Syndrome: A Variant Characterized by the Deficiency of Proa2 Chain of Type I Procollagen , 1987 .

[12]  A D McCulloch,et al.  Myocardial Mechanics and Collagen Structure in the Osteogenesis Imperfecta Murine (oim) , 2000, Circulation research.

[13]  H. Kodama,et al.  Molecular genetics and pathophysiology of Menkes disease , 1999, Pediatrics international : official journal of the Japan Pediatric Society.

[14]  R B Rucker,et al.  Enzymatic and nonenzymatic cross‐linking of collagen and elastin , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  R. Bank,et al.  Sensitive fluorimetric quantitation of pyridinium and pentosidine crosslinks in biological samples in a single high-performance liquid chromatographic run. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[16]  D. Prockop,et al.  The clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta. , 1984, Journal of medical genetics.

[17]  A G Patwardhan,et al.  Heterozygous oim mice exhibit a mild form of osteogenesis imperfecta. , 1996, Bone.

[18]  Y. Fung,et al.  Biomechanics: Mechanical Properties of Living Tissues , 1981 .

[19]  S. Birge,et al.  Lysyl Oxidase Is Required for Vascular and Diaphragmatic Development in Mice* , 2003, The Journal of Biological Chemistry.

[20]  B. Woodson,et al.  Perilymphatic Fistula: Analysis of Free Amino Acids in Middle Ear Microaspirates , 1991, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[21]  D. Heinegård,et al.  Glycosylated matrix protein , 2002 .

[22]  S. Jimenez,et al.  Identification of collagen α1(I) trimer in embryonic chick tendons and calvaria , 1977 .

[23]  J. Hanley,et al.  Cardiovascular involvement in osteogenesis imperfecta. , 1986, Circulation.

[24]  P. Byers,et al.  Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway. , 2004, American journal of human genetics.

[25]  A. Mitchell,et al.  Copper, lysyl oxidase, and extracellular matrix protein cross-linking. , 1998, The American journal of clinical nutrition.

[26]  I. Chervoneva,et al.  Type V Collagen Controls the Initiation of Collagen Fibril Assembly* , 2004, Journal of Biological Chemistry.

[27]  J. Uitto Collagen polymorphism: isolation and partial characterization of alpha 1(I)-trimer molecules in normal human skin. , 1979, Archives of biochemistry and biophysics.

[28]  A. Marty,et al.  The basic science of vascular disease , 1997 .

[29]  D. Birk,et al.  Reduction of type V collagen using a dominant-negative strategy alters the regulation of fibrillogenesis and results in the loss of corneal- specific fibril morphology , 1996, The Journal of cell biology.

[30]  S. Wallis,et al.  Homozygosity for a splice site mutation of the COL1A2gene yields a non-functional proα2(I) chain and an EDS/OI clinical phenotype , 2001, Journal of medical genetics.

[31]  W. Blackburn,et al.  Cardiovascular pathology in osteogenesis imperfecta type IIA with a review of the literature. , 1988, Pediatric pathology.

[32]  M T Davisson,et al.  Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  C. A. Miles,et al.  The role of the alpha2 chain in the stabilization of the collagen type I heterotrimer: a study of the type I homotrimer in oim mouse tissues. , 2002, Journal of molecular biology.

[34]  J. Exposito,et al.  Sea urchin collagen evolutionarily homologous to vertebrate pro-alpha 2(I) collagen. , 1992, The Journal of biological chemistry.

[35]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[36]  W. Landis The strength of a calcified tissue depends in part on the molecular structure and organization of its constituent mineral crystals in their organic matrix. , 1995, Bone.

[37]  T. Pihlajaniemi,et al.  Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene with a frameshift mutation. , 1984, The Journal of biological chemistry.

[38]  R. Brenner,et al.  Osteogenesis imperfecta in childhood: cardiac and renal manifestations , 1989, European Journal of Pediatrics.

[39]  P. Fratzl,et al.  Bone mineralization in an osteogenesis imperfecta mouse model studied by small-angle x-ray scattering. , 1996, The Journal of clinical investigation.

[40]  A L Boskey,et al.  The Material Basis for Reduced Mechanical Properties in oim Mice Bones , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[41]  B. Brodsky,et al.  Altered collagen structure in mouse tail tendon lacking the α2(I) chain , 1997 .